Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Nov 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how to improve colorectal cancer (CRC) screening in primary care clinics. Researchers want to find out if a new tool, called the "I2" tool, can help more patients get screened for CRC compared to the usual methods currently used in clinics. The trial involves 20 primary care clinics across the U.S., where they will use a specific method that encourages teamwork and communication among clinic staff and patients who prefer to speak Spanish. Eligible participants are adults aged 45 to 75 who need to be screened for CRC and have not had the necessary tests in the recommended timeframe.

If you or a loved one participate, you'll be asked to complete a simple online or paper survey about CRC screening. This tool will help the clinic staff know when and how to order the necessary tests for you. The study aims to involve at least 100 patients from each clinic during the first six months and will monitor how many patients get screened and how well the new tool works. Additionally, the researchers will gather feedback from staff and patients to understand any challenges or successes in using this new approach in everyday care. Your participation could help improve how clinics support patients in getting important cancer screenings.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinics participating in the DARTNet Institute /AAFP-affiliated NRN clinic serving communities in which at least 25% of the population prefers Spanish-language.
• • Clinic implementation teams Patients participating in implementation teams for whom Spanish is their preferred language, who are bilingual in English and Spanish, Clinics Staff will be included who have any contact regarding CRC screening with patients eligible for screening.
• Patients whose CRC screening outcomes will be monitored:
• • adults 45 to 75 years of age who are due for CRC screening, i.e. who have not received a high-sensitivity fecal occult blood test or a fecal immunochemical test within the past year, fecal DNA testing within 3 years, sigmoidoscopy or barium enema within 5 years, or colonoscopy within 10 years; and who receive primary care at least annually from the site.
• Exclusion Criteria:
• • patients ineligible for routine screening based on a personal or close family history of colorectal cancer or who have increased genetic risk of colon cancer.
• • cognitive or decisional incapacity will be excluded from the implementation teams, after completion of a brief, validate screening tool, the Mini-Cog Exam.